The nanomedicine global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Nanomedicine Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The nanomedicine market size has grown rapidly in recent years. It will grow from $292.72 billion in 2023 to $335.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increased understanding of molecular biology, growing incidence of chronic diseases, demand for targeted drug delivery systems, expansion of nanoparticle imaging technologies, growing aging popuation.
The nanomedicine market size is expected to see rapid growth in the next few years. It will grow to $594.63 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to continued growth in nanotechnology research, rising investments in nanomedicine r&d, increasing focus on personalized medicine, expanding applications of nanomedicine in cancer treatment, integration of nanomedicine in infectious disease therapeutics. Major trends in the forecast period include development of multifunctional nanoparticles for therapeutics and imaging, emphasis on nanoparticle-based diagnostics and imaging agents, application of nanomedicine in regenerative medicine, growing use of nanomedicine in targeted therapy for neurological disorders, collaboration and partnerships in nanomedicine research and commercialization.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/nanomedicine-global-market-report
Scope Of Nanomedicine Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The rising burden of complex and chronic diseases across the globe is expected to contribute to the growth of the nanomedicine market in the forecast period. Nanomedicine is increasingly being used in treating chronic diseases including cardiovascular disorders, diabetes, cancer, dementia, and others where it helps in the fast metabolism of drugs in the body. According to the international federation of Alzheimer’s Associations, Alzheimer’s Disease International, more than 50 million people are suffering from dementia globally, and is projected to double every 20 years, which will reach 80 million by 2030 and 152 million by 2050. The total cancer burden in the world is predicted to rise to 28.4 million new cancer cases in 2040. This increasing burden of chronic diseases is expected to propel the demand for effective therapeutics treatment based on nanomedicine, thus driving the growth of the nanomedicine market.
Market Trends –
Product innovations have emerged as the key trend gaining popularity in the 5G chipset market. The major players in the market are developing innovative products for market growth. For instance, in June 2021, Samsung Electronics, a South Korea-based electronics company, developed 3GPP Rel.16 compliant chipsets, a range of next-generation 5G chipsets that deliver cutting-edge 5G technologies. The new chipsets consist of a second-generation 5G modem System-on-Chip (SoC), a third-generation mmWave Radio Frequency Integrated Circuit (RFIC) chip, and a Digital Front End (DFE)-RFIC integrated chip. These are designed to increase power efficiency, boost performance, and reduce the size of 5G solutions.
The nanomedicine market covered in this report is segmented –
1) By Type: Nanoparticles, Nanoshells, Nanotubes, Nanodevices, Other Types
2) By Modality: Diagnostics, Treatments
3) By Application: Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Other Applications
Get an inside scoop of the nanomedicine market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=5344&type=smp
Regional Insights –
North America was the largest region in the nanomedicine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomedicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the nanomedicine market report are Pfizer Inc., Ablynx NV, Amgen Inc., Arrowhead Research Inc., Bio-Gate AG, Celgene Corporation, F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences Inc., Merck AG, Nanospectra Biosciences, Nanotherapeutics Inc., NanoViricides Inc, Novartis AG, Sanofi S. A., Abraxis Bioscience Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., AuraSense Therapeutics LLC, BIND Therapeutics Inc., Camurus AB, Cerulean Pharma Inc., CytImmune Sciences, Fujifilm Holdings, Nanobiosym Inc., Nanobiotix SA, Nanogen Inc., Nanomix Crop., Nanoparticle BioChem Inc., Nanospective Inc., Nanosphere Health Sciences Inc., Nanosys Inc., PerkinElmer Inc., Selecta Biosciences Inc., Sigma-Aldrich Co. LLC
Table of Contents
1. Executive Summary
2. Nanomedicine Market Report Structure
3. Nanomedicine Market Trends And Strategies
4. Nanomedicine Market – Macro Economic Scenario
5. Nanomedicine Market Size And Growth
…..
27. Nanomedicine Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
